Nicholas A. Kalogriopoulos

Intratumoral hu14.18–IL-2 (IC) Induces Local and Systemic Antitumor Effects That Involve Both Activated T and NK Cells As Well As Enhanced IC Retention

Richard K. Yang, Nicholas A. Kalogriopoulos, Alexander L. Rakhmilevich et al. · The Journal of Immunology · 2012 · 72 citations · Full text

Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the Hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival

Richard K. Yang, Nicholas A. Kalogriopoulos, Alexander L. Rakhmilevich et al. · Cancer Immunology Immunotherapy · 2013 · 49 citations · Full text

Cancer Immunosurveillance, Hu14.18 Antibody, Medicine +6

Structural basis for GPCR-independent activation of heterotrimeric Gi proteins

Nicholas A. Kalogriopoulos, Steven D. Rees, Tony Ngo et al. · Proceedings of the National Academy of Sciences · 2019 · 49 citations · Full text

Therapeutic effects of cell-permeant peptides that activate G proteins downstream of growth factors

S. Gary, Nicolas Aznar, Nicholas A. Kalogriopoulos et al. · Proceedings of the National Academy of Sciences · 2015 · 38 citations · Full text

Receptor tyrosine kinases activate heterotrimeric G proteins via phosphorylation within the interdomain cleft of Gαi

Nicholas A. Kalogriopoulos, Inmaculada López-Sánchez, Chang‐Shen Lin et al. · Proceedings of the National Academy of Sciences · 2020 · 34 citations · Full text